Approval · Notice of Compliance 8294 · 2006
SOTALOL: Notice of Compliance 8294
Issued October 2, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8294
- Date
- October 2, 2006
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Antiarrhythmic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOTALOL | 02286165 | — |
| SOTALOL | 02286173 | — |
| SOTALOL | 02286181 | — |
Medicinal ingredients
- SOTALOL HYDROCHLORIDE 80 MG per TAB
- SOTALOL HYDROCHLORIDE 160 MG per TAB
- SOTALOL HYDROCHLORIDE 240 MG per TAB